Literature DB >> 15027506

Quality-of-life measurement in clinical trials--the impact of causal variables.

Peter M Fayers1.   

Abstract

The theory of measurement scales, and in particular multi-item scales, has been extensively developed in educational testing, psychometric testing, personality testing, and consumer research. These scales are usually either based upon traditional psychometric models or modern theory using item response theory. However, clinical measuring instruments, including health-related quality-of-life questionnaires, frequently have different underlying principles and so the adoption of such approaches can be inappropriate. The fundamental statistical distinction between indicator and causal variables can be used to explain why psychometric methods fail. So-called clinimetric approaches may sometimes be more relevant, and clinimetric and psychometric ideas should be combined to yield a suitable measuring instrument. Recognition of the role of causal variables enables informed decisions to be made regarding scale development, validation, and scoring.

Mesh:

Year:  2004        PMID: 15027506     DOI: 10.1081/bip-120028512

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  11 in total

1.  What drives older women's perceptions of health-related quality of life?

Authors:  Cara Tannenbaum; Sara Ahmed; Nancy Mayo
Journal:  Qual Life Res       Date:  2007-02-01       Impact factor: 4.147

2.  Reflective, causal, and composite indicators of quality of life: A conceptual or an empirical distinction?

Authors:  Daniel S J Costa
Journal:  Qual Life Res       Date:  2015-03-01       Impact factor: 4.147

3.  Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire.

Authors:  Ellen M Lavoie Smith; Debra L Barton; Rui Qin; Preston D Steen; Neil K Aaronson; Charles L Loprinzi
Journal:  Qual Life Res       Date:  2013-03-30       Impact factor: 4.147

4.  Patient and societal value functions for the testing morbidities index.

Authors:  J Shannon Swan; Chung Yin Kong; Janie M Lee; Omosalewa Itauma; Elkan F Halpern; Pablo A Lee; Sergey Vavinskiy; Olubunmi Williams; Emilie S Zoltick; Karen Donelan
Journal:  Med Decis Making       Date:  2013-05-20       Impact factor: 2.583

5.  Is psychometric scoring of the McNew Quality of Life after Myocardial Infarction questionnaire superior to the clinimetric scoring? A comparison of the two approaches.

Authors:  A Ribera; G Permanyer-Miralda; J Alonso; P Cascant; N Soriano; C Brotons
Journal:  Qual Life Res       Date:  2006-04       Impact factor: 4.147

Review 6.  Assessing quality-of-life outcomes in cardiovascular clinical research.

Authors:  Daniel B Mark
Journal:  Nat Rev Cardiol       Date:  2016-02-18       Impact factor: 32.419

7.  Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data.

Authors:  Ellen M Lavoie Smith; Tanima Banerjee; James J Yang; Celia M Bridges; Paola Alberti; Jeff A Sloan; Charles Loprinzi
Journal:  Cancer Nurs       Date:  2019 May/Jun       Impact factor: 2.592

Review 8.  A critical review of scoring options for clinical measurement tools.

Authors:  Maria Laura Avila; Jennifer Stinson; Alex Kiss; Leonardo R Brandão; Elizabeth Uleryk; Brian M Feldman
Journal:  BMC Res Notes       Date:  2015-10-28

9.  Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours.

Authors:  G Yadegarfar; L Friend; L Jones; L M Plum; J Ardill; B Taal; G Larsson; K Jeziorski; D Kwekkeboom; J K Ramage
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

10.  In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials.

Authors:  Ellen M Lavoie Smith; Robert Knoerl; James J Yang; Grace Kanzawa-Lee; Deborah Lee; Celia M Bridges
Journal:  Cancer Control       Date:  2018 Jan-Mar       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.